drugset / Trial / NCT04505189
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
NaSingle-groupOpen-labelTreatment
Summary
The primary aim of this study is to assess the acceptability and efficacy of treating anorexia nervosa with psilocybin. The secondary aim of this study is to use Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG) to examine the neuronal underpinnings of treatment with psilocybin in this patient group.
Timeline
- Start
- 2021-05-28
- Primary completion
- 2023-12-11
- Completion
- 2024-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |